Genialis, Inc.
68 Harrison Ave #605
PMB 29417
Boston, MA 02111
Site map
Copyright © Genialis, Inc.
Genialis, the RNA biomarker company, is creating a world where healthcare delivers the best possible outcomes for patients, their families, and their communities. Genialis develops and validates clinically actionable biomarkers informed by the world’s most ethnographically diverse cancer data sets to better predict patient responses and guide treatment decisions for targeted inhibitors, immunotherapies, and other emerging therapeutic classes. Genialis is trusted by pharma and diagnostics partners, and together, we are revolutionizing precision oncology with RNA and AI.
Andrea Vuturo
Vuturo Group for Genialis
andrea@vuturo.com
+1-415-689-8414